NCT05409651View on ClinicalTrials.gov

Phenotyping Mitochondrial and Immune Dysfunction in POTS With Targeted Clinical Intervention.

NAActive, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

May 10, 2024

Study Completion Date

June 30, 2025

Conditions
Postural Tachycardia Syndrome
Interventions
BEHAVIORAL

Time restricted eating

Participants in this arm will adhere to a daily, consistent 8-10-hr eating window for the course of the study.

Trial Locations (1)

92093

Altman Clinical and Translational Research Institute, La Jolla

Sponsors
All Listed Sponsors
collaborator

Dysautonomia International

OTHER

lead

University of California, San Diego

OTHER

NCT05409651 - Phenotyping Mitochondrial and Immune Dysfunction in POTS With Targeted Clinical Intervention. | Biotech Hunter | Biotech Hunter